Iowa's medical cannabis program saw another year of growth in patient and provider participation, resulting in more than $10 million in sales by the end of 2022.
New data on the program was released in a report by the Iowa Cannabidiol Board in late December that offers recommendations to state lawmakers for proposed changes to the state program in the upcoming Legislative session.
Throughout 2022, the number of active cardholders certified to purchase medical cannabidiol products under the state program — which includes patients and caregivers designated to obtain products on behalf of a patient — ballooned.
Hundreds of patients obtained cards each month throughout 2022 until the total number of active patient cardholders reached nearly 15,000 individuals by November. That's compared to about 7,800 patients enrolled in December 2021.
Read more at desmoinesregister.com